Search Results 841-850 of 17046 for macronutrient manipulation

1. Overview - Microenvironments and Applied Nanomedicine Laboratory - Mayo Clinic Research

   The Microenvironments and Applied Nanomedicine Laboratory is dedicated to advancing precision medicine through cutting-edge research on nanomedicine, cancer ...

2. Infliximab Response in Inflammatory Bowel Disease - Mayo Clinic

   About this study. The specific objectives of this study are to define infliximab thresholds during induction therapy and during maintenance therapy (visit ...

3. A Study Of CS Reducer For Symptomatic Heart Failure With HFpEF And CMD - Mayo Clinic

   About this study. To evaluate the effect of CS reducer implantation in patients with HFPEF and CMD on myocardial ischemia, measured by stress myocardial ...

4. Mayo Clinic

   An error occurred, please try again later. Copy for customer care: session ID undefined. Try again. Share · Tweet . VID-20522544. Home; Clubfoot ...

5. A Study To Compare The Effectiveness And Safety Of ABT-493/ABT-530 To Sofosbuvir Given Together With Declatasvir In Adults With A Chronic Hepatitis C Virus Infection - Mayo Clinic

   A Study To Compare The Effectiveness And Safety Of ABT-493/ABT-530 To Sofosbuvir Given Together With Declatasvir In Adults With A Chronic Hepatitis C Virus ...

6. Defibrotide for Patients with Hepatic Veno-occlusive Disease: A Treatment IND Study - Mayo Clinic

   Single arm, open-label study to provide Defibrotide to patients diagnosed with VOD. Defibrotide is no longer available though the Emergency Use IND mechanism ( ...

7. A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Dupilumab in Adult Patients With Bullous Pemphigoid - Mayo Clinic

   The primary purpose of this study is to demonstrate that Dupilumab is superior to placebo in achieving sustained remission off oral corticosteroids (OCS) in ...

8. Gemcitabine Plus Cisplatin With or Without Bintrafusp Alfa (M7824) in Participants With 1L Biliary Tract Cancer (BTC) - Mayo Clinic

   Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

9. Study of Pembrolizumab (MK-3475) in Participants With Relapsed or Refractory Primary Mediastinal Large B-cell Lymphoma or Relapsed or Refractory Richter Syndrome (MK-3475-170/KEYNOTE-170) - Mayo Clinic

   In this study, participants with relapsed or refractory primary mediastinal large B-cell lymphoma (rrPMBCL) or relapsed or refractory Richter Syndrome (rrRS) ...

10. A Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Subjects With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Conventional Therapies But Have Not Failed Biologic Therapy - Mayo Clinic

    The objective of this study is to evaluate the efficacy and safety of upadacitinib compared to placebo as induction therapy in participants with moderately and ...